bioAffinity Technologies ... (BIAF)
NASDAQ: BIAF
· Real-Time Price · USD
0.29
0.01 (2.04%)
At close: Jun 09, 2025, 3:59 PM
bioAffinity Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.66M | -2.97M | -2M | -2.11M | -1.96M | -2.37M | -2.29M | -1.74M | -1.53M | -1.67M | -4.92M | -88.05K | -1.47M | -5.58M | -1.51M | 1.48M | -716.18K |
Depreciation & Amortization | 154.59K | 153.63K | 151.3K | 151.07K | 149.64K | 148.79K | 57.57K | 21.55K | 21.68K | 7.33K | 773.00 | 1.04K | 1.04K | 794.00 | 1.19K | 1.19K | 1.64K |
Stock-Based Compensation | 326.62K | 234.09K | 471.88K | 286.19K | 283.71K | 234.51K | 186.44K | 170.25K | 157.61K | 36.85K | 79.01K | 26.68K | 106.05K | -89.52K | -20.31K | 94.58K | 58.25K |
Other Working Capital | n/a | 511.93K | 469.22K | -323.52K | -293.77K | 563.95K | 1.41K | 238.52K | 29.29K | 60.52K | -304.58K | 115.74K | 145.46K | 282.17K | 129.07K | 87.53K | 95.02K |
Other Non-Cash Items | n/a | 234.09K | -1.01M | 286.19K | 1.11M | 722.47K | 4.84B | -170.25M | n/a | 82.68K | 3.82M | -768.02K | 574.02K | 679.75K | 852.16K | -1.89M | 111.48K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -722.47K | -4.84B | 170.25M | n/a | n/a | n/a | n/a | n/a | 4.08M | n/a | -239.2K | n/a |
Change in Working Capital | n/a | 902.02K | 676.92K | 140.59K | -817.51K | 373.56K | 514.36K | 188.42K | -175.55K | 247.09K | -742.04K | 452.2K | 156.94K | 253.09K | 39.42K | 188.06K | 152.26K |
Operating Cash Flow | -1.64M | -1.68M | -1.71M | -1.53M | -2.35M | -1.62M | -1.53M | -1.36M | -1.53M | -1.3M | -1.76M | -376.14K | -633.97K | -652.44K | -641.33K | -362.66K | -392.55K |
Capital Expenditures | -50.79K | -1 | -9.41K | -28.29K | -41.39K | 13.44K | -169 | -3.86K | -32.31K | -219.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 2.19M | -2.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -2.21M | n/a | n/a | -0.00 | -220K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -50.79K | -1 | -9.41K | -28.29K | -41.39K | 13.44K | -2.19M | -3.86K | -32.31K | -219.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | -187.95K | 170.85K | -91.29K | -60.94K | -84.81K | -50.77K | n/a | -83.32K | -563.37K | 458.5K | -34.97K | 475K | n/a | n/a | 650K | 212.26K |
Common Stock Repurchased | n/a | n/a | n/a | -494.85K | n/a | n/a | n/a | n/a | n/a | -185 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.17M | 27.77K | 1.34M | 147.00 | 74.9K | n/a | n/a | -126.1K | n/a | -185 | 14.59M | -402.52K | -173.64K | 1.77M | 370K | n/a | 325K |
Financial Cash Flow | 1.03M | 2.03M | 1.67M | -91.14K | 2.02M | -84.81K | -50.77K | -126.1K | -83.32K | -563.56K | 15.04M | -437.49K | 301.36K | 1.77M | 370K | 650K | 537.26K |
Net Cash Flow | -660.59K | 348.71K | -44.73K | -1.65M | -368.4K | -1.69M | -3.77M | -1.49M | -1.64M | -2.08M | 13.28M | -813.63K | -332.6K | 1.12M | -271.33K | 287.34K | 144.71K |
Free Cash Flow | -1.69M | -1.68M | -1.72M | -1.56M | -2.39M | -1.6M | -1.53M | -1.36M | -1.56M | -1.52M | -1.76M | -376.14K | -633.97K | -652.44K | -641.33K | -362.66K | -392.55K |